Diagnosis and management of iron deficiency in chronic inflammatory conditions (CIC): is too little iron making your patient sick? – Summary
Source Article: Fertrin, K. Y. (2020). Diagnosis and management of iron deficiency in chronic inflammatory conditions (CIC): is too little iron making your patient sick? Hematology, 2020(1), 478–486. https://doi.org/10.1182/hematology.2020000132 (Accessed via: https://ashpublications.org/hematology/article/2020/1/478/474369/Diagnosis-and-management-of-iron-deficiency-in)
The article examines the diagnosis and management of iron deficiency in chronic inflammatory conditions, where low-grade inflammation complicates the interpretation of iron status markers. It highlights that iron deficiency can cause symptoms even without anemia and is challenging to identify in conditions such as chronic kidney disease, cirrhosis, or heart failure. The author proposes a pragmatic approach to evaluating laboratory tests, including ferritin and transferrin saturation, to determine which patients would benefit from iron supplementation and to select between oral and intravenous options, particularly when standard guidelines do not apply.
A clinical case illustrates these challenges: a 56-year-old woman with rheumatoid arthritis, hypertension, type 2 diabetes, nonalcoholic fatty liver disease, and stage 3 chronic kidney disease presents with severe anemia, fatigue, dyspnea, and mental fogginess. Laboratory results show hemoglobin at 7.9 g/dL, ferritin at 89 μg/L, and elevated C-reactive protein, prompting evaluation beyond her underlying conditions.
The article distinguishes iron deficiency anemia, defined by low hemoglobin and microcytic, hypochromic red cells due to impaired heme synthesis, from broader iron deficiency, where iron availability fails to meet bodily needs, potentially without anemia. It notes that iron stores deplete before affecting red cell morphology or hemoglobin levels, and markers like percentage of hypochromic red cells or reticulocyte hemoglobin can indicate restricted erythropoiesis.
An included figure provides a visual framework for interpreting iron stores using ferritin and TSAT in CICs, with regions indicating deficiency risk: red (ferritin 0–30 μg/L) for likely deficiency in most CICs; yellow (30–200 μg/L, varying by TSAT and condition) for possible deficiency in CKD, ESA/dialysis cases, or heart failure; green (200–800 μg/L) for adequate stores with potential functional deficiency; dark green (800–1000 μg/L) for adequate stores but possible overload with IV iron; and gray (above 1000 μg/L or TSAT >50%) prompting overload investigation.
Key Themes
Tags: #IronDeficiencyDiagnosis #ChronicInflammationEffects #AnemiaManagement #IronHomeostasis #SupplementationStrategies